TERT and liver cancer: Our study suggests that MEG3 promotes the expression of TERRA and thus enhances the binding of TERRA to TERT, competitively inhibits the interaction of TERC with TERT, and ultimately inhibits telomerase activity in human liver cancer stem cells.